We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. I saw three patients recently. One was an established ...

What is lipodystrophy and why is it so rare? Lipodystrophy is a condition that impacts a person’s ability to produce and store fat. It can be categorised into different forms, including acquired and ...

The US Food and Drug Administration (FDA) has approved Amylin Pharmaceuticals' Myalept (metreleptin for injection) as replacement therapy to treat the complications of leptin deficiency, in addition ...

Lipodystrophy is a term used to describe a group of varying disorders which are characterized by abnormal loss of body fat over some or all body areas, with a strong tendency to develop insulin ...

Lipodystrophy is a medical condition characterized by complete or partial loss of adipose tissue. Not infrequently, lipodystrophy occurs in combination with pathological accumulation of adipose tissue ...

Please provide your email address to receive an email when new articles are posted on . Evidence remains limited regarding diagnostic criteria and recommendations for the treatment of lipodystrophy in ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest analysis report on drug pipeline for lipodystrophy syndrome. The report includes a detailed analysis of the pipeline molecules under ...

May 9, 2011 (San Diego, California) — An investigational drug that is an analog of leptin has the potential to help patients with lipodystrophy. The leptin analog metreleptin (Amylin Pharmaceuticals) ...

The adipocyte hormone leptin is important in regulating energy homeostasis. Since severe lipodystrophy is associated with leptin deficiency, insulin resistance, hypertriglyceridemia, and hepatic ...